Concepedia

Guoju Geng

GG

Statistics

Publications

2

Citations

84

H-Index

2

Active since

1997

Affiliations

Gilead Sciences (United States)(Current)

Guoju Geng is an author at Gilead Sciences (United States) specializing in pharmacology, medicine, and therapeutic tyrosine kinase inhibitors.

Publications per year

1997–2020

2

Publications

2

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases

Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo et al. · ACS Medicinal Chemistry Letters · 2020 · 53 citations · Full text

, , +13

Role of L-type Ca<sup>2+</sup> channel in PACAP-induced adrenal catecholamine release in vivo

Guoju Geng, Rania Gaspo, Fethi Trabelsi et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1997 · 31 citations

, , +17

1–2 of 2